Adams Wealth Management

Position in MRK — Merck & Co., Inc.

CIK 1803084 LOGAN, UT

Position in MRK

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$253,145

+$49,495 QoQ

Shares Held

1,970

+16.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#3,335

of 3,768 holders

Holding Since

Sep 2020

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Adams Wealth Management holds $3,392,754 across 6 Drug Manufacturers - General names. MRK ranks #6 (7.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc.	6,766	$854,816
2	BMY	Bristol Myers Squibb Co	14,065	$810,425
3	ABBV	AbbVie Inc.	3,177	$799,460
4	LLY	ELI LILLY & Co	328	$393,413
5	PFE	Pfizer Inc	11,690	$281,495
6	MRK	Merck & Co., Inc. This page	1,970	$253,145

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$253,145	1,970	+16.4%	Shares	Other	2026-08-10
2026-03-31	$203,650	1,693	+33.2%	Shares	Other	2026-05-12
2020-09-30	$105,429	1,271	—	Shares	Sole	2020-11-12
No filing history on record for this holder in this stock.